Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (241-250 of 308) with videos related to

Pageof 31
Sort By:
Journal of Thrombosis and Thrombolysis|July 24, 2013
Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practicesRobby Nieuwlaat, John W Eikelboom, Sam Schulman, et al.
Chest|February 9, 2012
Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSusan R Kahn, Wendy Lim, Andrew S Dunn, et al.
Chest|February 22, 2017
Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational StudyYan Xu, Sam Schulman, Dar Dowlatshahi, et al.
Thrombosis Research|August 22, 2019
Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleedingYan Xu, Sam Schulman, Dar Dowlatshahi, et al.
Clinical and Translational Gastroenterology|August 16, 2018
Long-Term Outcome of Splanchnic Vein Thrombosis in CirrhosisMarco Senzolo, Nicoletta Riva, Francesco Dentali, et al.
Journal of Clinical Medicine|October 27, 2022
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical TrialsKonstantinos G Kyriakoulis, Evangelos Dimakakos, Ioannis G Kyriakoulis, et al.
The Journal of Infectious Diseases|January 29, 2003
Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virusAstrid K N Iversen, Claus Bohn Christiansen, Jørn Attermann, et al.
Anticancer Research|July 5, 2022
Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-ArtEvangelos Dimakakos, Georgia Gomatou, Mariella Catalano, et al.
Thrombosis and Haemostasis|September 28, 2012
Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapyRobby Nieuwlaat, Lowiek M Hubers, Alex C Spyropoulos, et al.
Journal of Thrombosis and Haemostasis : JTH|January 29, 2023
The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolismLucia Caiano, Michael J Kovacs, Alejandro Lazo-Langner, et al.
Pageof 31

Showing results (241-250 of 308) with videos related to

Sort By:
Pageof 31
Journal of Thrombosis and Thrombolysis|July 24, 2013
Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practicesRobby Nieuwlaat, John W Eikelboom, Sam Schulman, et al.
Chest|February 9, 2012
Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSusan R Kahn, Wendy Lim, Andrew S Dunn, et al.
Chest|February 22, 2017
Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational StudyYan Xu, Sam Schulman, Dar Dowlatshahi, et al.
Thrombosis Research|August 22, 2019
Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleedingYan Xu, Sam Schulman, Dar Dowlatshahi, et al.
Clinical and Translational Gastroenterology|August 16, 2018
Long-Term Outcome of Splanchnic Vein Thrombosis in CirrhosisMarco Senzolo, Nicoletta Riva, Francesco Dentali, et al.
Journal of Clinical Medicine|October 27, 2022
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical TrialsKonstantinos G Kyriakoulis, Evangelos Dimakakos, Ioannis G Kyriakoulis, et al.
The Journal of Infectious Diseases|January 29, 2003
Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virusAstrid K N Iversen, Claus Bohn Christiansen, Jørn Attermann, et al.
Anticancer Research|July 5, 2022
Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-ArtEvangelos Dimakakos, Georgia Gomatou, Mariella Catalano, et al.
Thrombosis and Haemostasis|September 28, 2012
Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapyRobby Nieuwlaat, Lowiek M Hubers, Alex C Spyropoulos, et al.
Journal of Thrombosis and Haemostasis : JTH|January 29, 2023
The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolismLucia Caiano, Michael J Kovacs, Alejandro Lazo-Langner, et al.
Pageof 31